Clinical Trials Directory

Trials / Unknown

UnknownNCT04277260

Molecular Structure and Content of Human Milk Oligosaccharides (HMOs) and Its Effect on Infant Health in China

Study on the Molecular Structure and Content of Human Milk Oligosaccharides (HMOs) in Breast Milk and Its Effect on Infant Health in China

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Heilongjiang Feihe Dairy Co. Ltd. · Industry
Sex
All
Age
7 Days – 35 Years
Healthy volunteers

Summary

In the study, the composition and content of human milk oligosaccharides in premature delivery mothers in China will be examined to investigate the differences in oligosaccharide concentrations in preterm breast milk from different gestational weeks. This study will fill a gap in human milk research in China, provide theoretical basis for the superiority of breastfeeding, and provide more powerful nutritional support for the catch-up growth of preterm infants

Detailed description

Objective: 1. Analyze and compare the differences in HMOs components among mothers who give birth at different gestational weeks; 2. Longitudinal observation of weekly changes in HMOs concentrations of premature mothers within 1 month of delivery; 3. Validate the association between HMOs components in preterm mothers and fecal intestinal flora in infants at 6 months of age. Research content 1. The LC-MS method will be used to detect the content of HMOs in preterm mothers and compared with the corresponding components in term breast milk during the postpartum period to analyze the effects of different gestational weeks on HMOs; 2. The intestinal flora 16S rDNA high-throughput sequencing method will be used to determine the bacterial gene profile in the fecal DNA samples of infants, and the differences between the gestational age groups (term and preterm infants) were compared, and the preterm infants in this group were plotted Evolution of intestinal flora within 6 months of birth; 3. Use statistical methods to verify the association between HMOs components in preterm mothers and the establishment of intestinal flora in infants.

Conditions

Timeline

Start date
2019-04-08
Primary completion
2021-10-01
Completion
2022-04-01
First posted
2020-02-20
Last updated
2020-02-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04277260. Inclusion in this directory is not an endorsement.